China Resources Pharmaceutical Group Appoints New Non-Executive Director

The latest update is out from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ).

China Resources Pharmaceutical Group Ltd. has appointed Mr. Wang Yuhang as a non-executive director, effective June 18, 2025. Mr. Wang brings extensive experience from various roles within China Resources Group and other organizations, enhancing the company’s leadership team. His appointment is expected to strengthen the company’s strategic direction and governance, although he will not receive any director’s emolument and holds no shares in the company.

The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.

More about China Resources Pharmaceutical Group Ltd.

China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. It is part of the larger China Resources Group, which has diverse business units including environmental health and safety, and chemical innovative materials.

Average Trading Volume: 12,543,088

Technical Sentiment Signal: Buy

Current Market Cap: HK$33.55B

Learn more about 3320 stock on TipRanks’ Stock Analysis page.